Adage Capital Partners Gp, L.L.C. Bolt Biotherapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 500,000 shares of BOLT stock, worth $310,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500,000
Previous 500,000
-0.0%
Holding current value
$310,000
Previous $700,000
46.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BOLT
# of Institutions
38Shares Held
23MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$2.36 Million0.35% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$2.18 Million0.39% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$1.71 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.37MShares$1.47 Million0.0% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$1.17 Million1.28% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $23.3M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...